Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biogen Inc Wants to Be the "Fastest-Growing Large-Cap Biotech Company"

TheMotleyFool 
0 0 26.07.17
Biogen Inc Wants to Be the "Fastest-Growing Large-Cap Biotech Company"
 
Biogen Inc Wants to Be the "Fastest-Growing Large-Cap Biotech Company"

Biogen (NASDAQ: BIIB) started the biotech earnings season off with a bang, generating enough revenue for the company to have confidence to increase its revenue guidance for the year. Earnings weren't nearly as hot, but Biogen has a good excuse: one-time investments in the company's future that lowered the bottom-line results. Beyond the profit-loss statement, Biogen laid out plans for diversifying away from its multiple sclerosis (MS) franchise as it looks to accelerate growth.

Metric

Q2 2017

Continue reading


Source: Fool.com

Bristol-Myers Squibb Stock

€46.46
11.400%
Bristol-Myers Squibb dominated the market today, gaining €4.76 (11.400%).
With 8 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 70 € shows a very positive potential of 50.67% compared to the current price of 46.46 € for Bristol-Myers Squibb.
Show more
Like: 0
BMY
Share

Comments

Not a member yet? Sign up for free!